Cytokinetics

Cardiovascular Account Specialist - U.S. Sales, Dallas North, TX

Remote

Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Pharmaceuticals, Medical DevicesIndustries

Position Overview

  • Location Type: Remote (Plano, TX and McKinney, TX territory)
  • Employment Type: Full-time
  • Salary: (Salary not provided in the text)

Cytokinetics is a late-stage, specialty cardiovascular biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which cardiac muscle performance is compromised. The company is developing small molecule drug candidates specifically engineered to impact myocardial muscle function and contractility. Our passion is anchored in our four core values: Patients are our North Star, Science is in our Soul, We > Me, and Make it Happen.

Requirements

  • Education: Bachelor’s Degree required
  • Experience: 5+ years of experience in biotech/pharma sales required
  • Territory Ownership: Experience as a rep with sole ownership of the territory is highly preferred
  • Preferred Experience:
    • Cardiology, rare disease, or specialty product experience
    • Specialty product launch experience

Responsibilities

  • Sales Performance: Deliver sales results and serve as the single point of accountability for the successful launch within your territory.
  • Account Planning: Develop territory-specific account plans to identify, assess, and prioritize opportunities to meet customer needs.
  • Integrated Field Team Collaboration: Work synergistically with internal stakeholders (medical, payer, and patient navigation/support colleagues) and external customers.
  • Subject Matter Expertise: Be a subject matter expert and resource to customers, delivering clinically relevant disease and product information.
  • Demand Generation: Communicate approved resources (marketing materials, payer information, formulary coverage, patient support services, and educational programs) to HCPs to create demand for the product launch.
  • Patient Focus: Focus on helping HCM patients.

Application Instructions

  • (Application instructions not provided in the text)

Company Information

  • Company: Cytokinetics
  • Industry: Cardiovascular Biopharmaceutical
  • Focus: Discovering, developing, and commercializing muscle activators and inhibitors for diseases compromising cardiac muscle performance.
  • Core Values: Patients are our North Star, Science is in our Soul, We > Me, and Make it Happen.

Skills

Biotech sales
Pharmaceutical sales
Cardiology
Rare disease
Specialty product
Account planning
Territory management
Stakeholder collaboration
Clinical knowledge
Demand generation
Customer engagement

Cytokinetics

Develops drugs for muscle function disorders

About Cytokinetics

Cytokinetics focuses on developing medicines that improve muscle function for patients with cardiovascular and neuromuscular diseases. Their products are small molecule drugs designed to either enhance or inhibit muscle function, tailored to specific therapeutic needs. The company has a pipeline of drugs, including omecamtiv mecarbil and reldesemtiv, which are in various stages of clinical trials. Unlike many competitors, Cytokinetics emphasizes rigorous scientific research and has conducted over 50 clinical trials to ensure the effectiveness of its treatments. The goal is to bring new therapies to market that address the unmet needs of patients suffering from conditions like heart failure, ALS, and HCM.

South San Francisco, CaliforniaHeadquarters
1998Year Founded
$58.4MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
501-1,000Employees

Risks

Increased competition could impact market share and profitability.
Potential delays in clinical trials could hinder drug commercialization.
Dependence on strategic partnerships may expose Cytokinetics to risks if challenges arise.

Differentiation

Cytokinetics focuses on muscle activators and inhibitors for cardiovascular and neuromuscular diseases.
The company has a robust pipeline including omecamtiv mecarbil and aficamten.
Cytokinetics engages in strategic partnerships, like with Sanofi, to expand market reach.

Upsides

Recent investments indicate strong interest in muscle activators and inhibitors.
Strategic partnerships, like with Sanofi, expand market reach and potential revenue.
Significant funding from Royalty Pharma supports commercial launch and R&D advancements.

Land your dream remote job 3x faster with AI